1 Executive Summary1.1 Omics CRO Services – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Omics CRO Services Market Definition And Segmentations
6.4 Market Segmentation By Type Of Omics Services
6.4.1 Genomics
6.4.2 Transcriptomics
6.4.3 Proteomics
6.4.4 Metabolomics
6.4.5 Lipidomics
6.4.6 Multiomics
6.4.7 Single-Cell Omics
6.4.8 Other Type Of Omics Services
6.5 Market Segmentation By Technology Platform
6.5.1 Next-Generation Sequencing (NGS)
6.5.2 Microarray Technology
6.5.3 Mass Spectrometry
6.5.4 Chromatography
6.5.5 Bioinformatics Tools
6.5.6 Other Technology Platforms
6.6 Market Segmentation By Application
6.6.1 Drug Discovery And Development
6.6.2 Diagnostics
6.6.3 Personalized Medicine
6.6.4 Other Applications
6.7 Market Segmentation By End Users
6.7.1 Research And Academic Institutions
6.7.2 Pharmaceutical And Biotechnology Companies
6.7.3 Clinical And Diagnostic Laboratories
7 Major Market Trends
7.1 Strategic Collaborations To Enhance Technology Integration
7.2 Strategic Collaborations Driving Advanced Spatial Transcriptomics
7.3 Next-Generation Organoid-Based Screening Solutions
8 Global Omics CRO Services Growth Analysis And Strategic Analysis Framework
8.1 Global Omics CRO Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Environmental
8.1.6 Legal
8.2 Analysis Of End Users (B2B)
8.2.1 Research And Academic Institutions
8.2.2 Pharmaceutical And Biotechnology Companies
8.2.3 Clinical And Diagnostic Laboratories
8.3 Global Omics CRO Services Market Size And Growth Analysis
8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)
8.4.1 Market Drivers 2019 – 2024
8.4.2 Market Restraints 2019 – 2024
8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
8.6.1 Quantitative Growth Contributors
8.6.2 Drivers
8.6.3 Restraints
8.7 Total Addressable Market for the Omics CRO Services Market – Business To Business (B2B)
8.7.1 TAM Comparison Analysis
9 Global Omics CRO Services Market Segmentation
9.1 Global Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 China Market
10.1 Market Overview
10.1.1 Country Information
10.1.2 Market Information
10.1.3 Background Information
10.1.4 Government Initiatives
10.1.5 Regulations
10.1.6 Regulatory Bodies
10.1.7 Major Associations
10.1.8 Taxes Levied
10.1.9 Corporate Tax Structure
10.1.10 Investments
10.1.11 Major Companies
10.2 China Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.3 China Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.4 China Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.5 China Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.6 China Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.7 India Market
10.8 India Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.9 India Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.10 India Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.11 India Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.12 India Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Japan Market
11.1 Market Overview
11.1.1 Country Information
11.1.2 Market Information
11.1.3 Background Information
11.1.4 Government Initiatives
11.1.5 Regulations
11.1.6 Regulatory Bodies
11.1.7 Major Associations
11.1.8 Taxes Levied
11.1.9 Corporate Tax Structure
11.1.10 Investments
11.1.11 Major Companies
11.2 Japan Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.3 Japan Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.4 Japan Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.5 Japan Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.6 Japan Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Europe Market
12.1 Market Overview
12.1.1 Region Information
12.1.2 Market Information
12.1.3 Background Information
12.1.4 Government Initiatives
12.1.5 Regulations
12.1.6 Regulatory Bodies
12.1.7 Major Associations
12.1.8 Taxes Levied
12.1.9 Corporate Tax Structure
12.1.10 Investments
12.1.11 Major Companies
12.2 Europe Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.3 Europe Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.4 Europe Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.5 Europe Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.6 Europe Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.7 Europe Omics CRO Services Market: Country Analysis
12.8 UK Market
12.9 UK Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.11 UK Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.12 UK Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.13 UK Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Market
12.15 Germany Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.16 Germany Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.17 Germany Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.18 Germany Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.19 Germany Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.20 France Market
12.21 France Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.22 France Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.23 France Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.24 France Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.25 France Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.26 Italy Market
12.27 Italy Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.28 Italy Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.29 Italy Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.30 Italy Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.31 Italy Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.32 Spain Market
12.33 Spain Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.34 Spain Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.35 Spain Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.36 Spain Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.37 Spain Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.38 Rest Of Europe Market
12.39 Rest Of Europe Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.40 Rest Of Europe Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.41 Rest Of Europe Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.42 Rest Of Europe Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.43 Rest Of Europe Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 USA Market
13.1 Market Overview
13.1.1 Country Information
13.1.2 Market Information
13.1.3 Background Information
13.1.4 Government Initiatives
13.1.5 Regulations
13.1.6 Regulatory Bodies
13.1.7 Major Associations
13.1.8 Taxes Levied
13.1.9 Corporate Tax Structure
13.1.10 Investments
13.1.11 Major Companies
13.2 USA Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.3 USA Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.4 USA Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.5 USA Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.6 USA Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 Canada Market
14.1 Market Overview
14.1.1 Country Information
14.1.2 Market Information
14.1.3 Background Information
14.1.4 Government Initiatives
14.1.5 Regulations
14.1.6 Regulatory Bodies
14.1.7 Major Associations
14.1.8 Taxes Levied
14.1.9 Corporate Tax Structure
14.1.10 Investments
14.1.11 Major Companies
14.2 Canada Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.3 Canada Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.4 Canada Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.5 Canada Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.6 Canada Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 Global Competitive Landscape And Company Profiles
15.1 Company Profiles
15.2 Labcorp Holding Inc. (including Covance)
15.2.1 Company Overview
15.2.2 Products And Services
15.2.3 Financial Overview
15.3 Thermo Fisher Scientific Inc. (PPD)
15.3.1 Company Overview
15.3.2 Products And Services
15.3.3 Business Strategy
15.3.4 Financial Overview
15.4 Charles River Laboratories International Inc.
15.4.1 Company Overview
15.4.2 Products And Services
15.4.3 Financial Overview
15.5 Eurofins Scientific SE
15.5.1 Company Overview
15.5.2 Products And Services
15.5.3 Financial Overview
15.6 BGI Genomics Co. Ltd.
15.6.1 Company Overview
15.6.2 Products And Services
15.6.3 Financial Overview
16 Other Major And Innovative Companies
16.1 Novogene Co. Ltd.
16.1.1 Company Overview
16.1.2 Products And Services
16.2 GENEWIZ from Azenta
16.2.1 Company Overview
16.2.2 Products And Services
16.3 Frontage Laboratories
16.3.1 Company Overview
16.3.2 Products And Services
16.4 Somalogic Inc. (SomaScan®)
16.4.1 Company Overview
16.4.2 Products And Services
16.5 Metabolon Inc.
16.5.1 Company Overview
16.5.2 Products And Services
17 Information On Strengths And Weaknesses Of Top 10 Global Companies
17.1 Labcorp Holding Inc. (including Covance)
17.1.1 Strengths
17.1.2 Weaknesses
17.2 Thermo Fisher Scientific Inc. (PPD)
17.2.1 Strengths
17.2.2 Weaknesses
17.3 Charles River Laboratories
17.3.1 Strengths
17.3.2 Weaknesses
17.4 Eurofins Scientific SE
17.4.1 Strengths
17.4.2 Weaknesses
17.5 BGI Genomics Co. Ltd.
17.5.1 Strengths
17.5.2 Weaknesses
17.6 Novogene Co. Ltd.
17.6.1 Strengths
17.6.2 Weaknesses
17.7 GENEWIZ from Azenta
17.7.1 Strengths
17.7.2 Weaknesses
17.8 Frontage Laboratories
17.8.1 Strengths
17.8.2 Weaknesses
17.9 Somalogic Inc. (SomaScan®)
17.9.1 Strengths
17.9.2 Weaknesses
17.10 Metabolon Inc.
17.10.1 Strengths
17.10.2 Weaknesses
18 Information On AI/ML Capabilities Of Top 10 Global Companies
18.1 Labcorp Holding Inc. (Including Covance)
18.1.1 Bioinformatics And Genomics Pipelines (NGS, Expression, Multi-Omics)
18.1.2 Clinical and Real-World Data (RWD) with Predictive Analytics
18.1.3 Digital Pathology And Image-Based AI
18.1.4 Cloud Infrastructure and Generative-AI Clinician Tools
18.1.5 Partnerships And External AI/ML Collaborations
18.2 Thermo Fisher Scientific Inc. (PPD)
18.2.1 Accelerator™ Drug Development Platform
18.2.2 AI-Powered Clinical Trial Forecasting
18.2.3 PPD™ TrueCast AI Solution
18.2.4 Partnership with OpenAI
18.2.5 Integration of AI in Laboratory Services
18.3 Charles River Laboratories
18.3.1 Logica: AI-Powered Drug Discovery Platform
18.3.2 Collaborations with Aitia and Related Sciences
18.3.3 Integration of Omics and New Approach Methodologies
18.4 Eurofins Scientific SE
18.4.1 Eurofins DiscoveryAI: SAFIRE Platform
18.4.2 Eurofins Viracor Bioinformatics & AI Center of Excellence
18.4.3 Cloud-Based Data Analysis Infrastructure
18.5 BGI Genomics Co. Ltd.
18.5.1 GeneT: AI-Powered Genomic Consultation Platform
18.5.2 iGeneT Pro: Comprehensive Bioinformatics Analysis
18.5.3 133111i Multi-Omics Precision Health Management System
18.5.4 Dr. Tom: Multi-Omics Data Visualization System
18.5.5 Multi-Omics Services for Research and Drug Discovery
18.6 Novogene Co. Ltd.
18.6.1 NovoMagic: Cloud-Based Bioinformatics Platform
18.6.2 Novi: AI-Powered RNA-Seq Analysis Assistant
18.6.3 C2-Intelligence Platform: AI-Powered Cancer Detection
18.6.4 Multi-Omics Services for Research and Drug Discovery
18.7 GENEWIZ from Azenta
18.7.1 Strategic Partnership with Form Bio
18.7.2 Advanced Sequencing Technologies
18.7.3 3. Comprehensive Bioinformatics Solutions
18.7.4 Multi-Omics Services for Research and Drug Discovery
18.8 Frontage Laboratories
18.8.1 Genomics and Omics Services
18.8.2 Drug Discovery and Development Services
18.8.3 Biomarker and Precision Medicine
18.8.4 AI/ML Integration in Omics Services
18.9 Somalogic Inc. (SomaScan®)
18.9.1 AI/ML Integration in SomaScan® Proteomics
18.9.2 Omics CRO Servicesand Capabilities
18.9.3 High-Throughput Proteomics
18.9.4 Biomarker Discovery
18.9.5 Clinical and Translational Research
18.10 Metabolon Inc.
18.10.1 Automate Data Curation
18.10.2 Identify Biochemical Signatures
18.10.3 Anomaly Detection
19 Information On Innovations By Top 10 Global Companies Including Description Of Type Of Innovation
19.1 Labcorp Holding Inc. (Including Covance)
19.1.1 Next-Generation Sequencing (NGS) Panel Advancements
19.2 Thermo Fisher Scientific Inc. (PPD)
19.2.1 Expansion of Bioanalytical Laboratory Services in Europe
19.2.2 R&D Partnership with AstraZeneca BioVentureHub
19.3 Charles River Laboratories
19.3.1 Omics and New Approach Methodologies (NAMs) Integration
19.3.2 Automation in Spatial Biology
19.4 Eurofins Scientific SE
19.4.1 Partnership with Hurdle to Enhance Omics Testing Access
19.4.2 Integration of Omics Technologies with New Approach Methodologies (NAMs)
19.5 BGI Genomics Co. Ltd.
19.5.1 Collaboration with Saudi Arabia's National Unified Procurement Company
19.6 Novogene Co. Ltd.
19.6.1 Launch of Spatial Transcriptomics Service
19.6.2 Establishment of Novogene Korea Limited
19.6.3 Certification as Olink® Certified Service Provider
19.7 GENEWIZ from Azenta
19.7.1 Launch of Clinical Long-Read Whole Genome Sequencing Test
19.7.2 Strategic Partnership with Form Bio for AAV Gene Therapy
19.7.3 GENEWIZ Week 2025 Workshops
19.8 Frontage Laboratories
19.8.1 Strategic Collaboration with Medicover Integrated Clinical Services
19.8.2 Participation in the 2025 EMGS Annual Meeting
19.8.3 Expansion of Global Drug Discovery and DMPK Leadership
19.9 Somalogic Inc. (SomaScan®)
19.9.1 Expansion of SomaScan® 11K Platform
19.9.2 Early Access Program with Illumina Sequencers
19.9.3 SomaScan® Assay Powers Key Insights into Semaglutide Treatment
19.9.4 Illumina's Acquisition of SomaLogic
19.10 Metabolon Inc.
19.10.1 Launch of Integrated Bioinformatics Platform
19.10.2 Introduction of 4-Week Turnaround Time for Commercial Projects
19.10.3 Launch of Microbiome Research Solution
19.10.4 Expansion of Integrated Bioinformatics Platform
20 Information On Technologies Used Specifically For Proteomics, Metabolomics And Lipidomics Platforms/Projects By Top 10 Global Companies
20.1 Labcorp Holding Inc. (including Covance)
20.1.1 Proteomics Technologies
20.1.2 Metabolomics Technologies
20.1.3 Lipidomics Technologies
20.2 Thermo Fisher Scientific Inc.
20.2.1 Proteomics Technologies
20.2.2 Metabolomics Technologies
20.2.3 Lipidomics Technologies
20.3 Charles River Laboratories
20.3.1 Proteomics Technologies
20.3.2 Metabolomics Technologies
20.3.3 Lipidomics Technologies
20.4 Eurofins Scientific SE
20.4.1 Proteomics Technologies
20.4.2 Metabolomics Technologies
20.4.3 Lipidomics Technologies
20.5 BGI Genomics Co. Ltd.
20.5.1 Proteomics Technologies
20.5.2 Metabolomics Technologies
20.5.3 Lipidomics Technologies
20.6 Novogene Co. Ltd.
20.6.1 Proteomics Technologies
20.6.2 Metabolomics Technologies
20.6.3 Lipidomics Technologies
20.7 GENEWIZ from Azenta
20.7.1 Proteomics Technologies
20.7.2 Metabolomics Technologies:
20.7.3 Lipidomics Technologies:
20.8 Frontage Laboratories
20.8.1 Proteomics Technologies
20.8.2 Metabolomics Technologies
20.8.3 Lipidomics Technologies
20.9 Somalogic Inc. (SomaScan)
20.9.1 Proteomics Technologies
20.9.2 Metabolomics Technologies
20.9.3 Lipidomics Technologies
20.10 Metabolon Inc.
20.10.1 Proteomics Technologies
20.10.2 Metabolomics Technologies
20.10.3 Lipidomics Technologies
21 Information On Overall Capabilities And Technologies Including Coverage, Dynamic Range, Sensitivity And Reproducibility For Top 10 Global Companies
21.1 Labcorp Holding Inc. (including Covance)
21.1.1 Overall Capabilities & Technologies
21.1.2 Coverage
21.1.3 Dynamic Range
21.1.4 Sensitivity
21.1.5 Reproducibility
21.2 Thermo Fisher Scientific Inc. (PPD)
21.2.1 Overall Capabilities & Technologies
21.2.2 Coverage
21.2.3 Dynamic Range
21.2.4 Sensitivity
21.2.5 Reproducibility
21.3 Charles River Laboratories
21.3.1 Overall Capabilities & Technologies
21.3.2 Coverage
21.3.3 Dynamic Range
21.3.4 Sensitivity
21.3.5 Reproducibility
21.4 Eurofins Scientific SE
21.4.1 Overall Capabilities & Technologies
21.4.2 Coverage
21.4.3 Dynamic Range
21.4.4 Sensitivity
21.4.5 Reproducibility
21.5 BGI Genomics Co. Ltd.
21.5.1 Overall Capabilities & Technologies
21.5.2 Coverage
21.5.3 Dynamic Range
21.5.4 Sensitivity
21.5.5 Reproducibility
21.6 Novogene Co. Ltd.
21.6.1 Overall Capabilities & Technologies
21.6.2 Coverage
21.6.3 Dynamic Range
21.6.4 Sensitivity
21.6.5 Reproducibility
21.7 GENEWIZ from Azenta
21.7.1 Overall Capabilities & Technologies
21.7.2 Coverage
21.7.3 Dynamic Range
21.7.4 Sensitivity
21.7.5 Reproducibility
21.8 Frontage Laboratories
21.8.1 Overall Capabilities & Technologies
21.8.2 Coverage
21.8.3 Dynamic Range
21.8.4 Sensitivity
21.8.5 Reproducibility
21.9 Somalogic Inc. (SomaScan)
21.9.1 Overall Capabilities & Technologies
21.9.2 Coverage
21.9.3 Dynamic Range
21.9.4 Sensitivity
21.9.5 Reproducibility
21.10 Metabolon Inc.
21.10.1 Overall Capabilities & Technologies
21.10.2 Coverage
21.10.3 Dynamic Range
21.10.4 Sensitivity
21.10.5 Reproducibility
22 List Of Key Players In The Omics CRO Services Market
22.1 Key Players In The Omics Contract Research Organization (CRO) Services Market
23 Europe Competitive Landscape And Company Profiles
23.1 Company Profiles
23.2 Charles River Laboratories International Inc.
23.2.1 Company Overview
23.2.2 Products And Services
23.3 Labcorp Holdings Inc.
23.3.1 Company Overview
23.3.2 Products And Services
23.4 Thermo Fisher Scientific Inc.
23.4.1 Company Overview
23.4.2 Products And Services
23.5 Eurofins Scientific SE.
23.5.1 Company Overview
23.5.2 Products And Services
23.6 BGI Genomics Co. Ltd.
23.6.1 Company Overview
23.6.2 Products And Services
23.7 Novogene Co. Ltd.
23.7.1 Company Overview
23.7.2 Products And Services
23.8 GENEWIZ from Azenta
23.8.1 Company Overview
23.8.2 Products And Services
23.9 Frontage Laboratories
23.9.1 Company Overview
23.9.2 Products And Services
23.10 Somalogic Inc.
23.10.1 Company Overview
23.10.2 Products And Services
23.11 Metabolon Inc.
23.11.1 Company Overview
23.11.2 Products And Services
24 UK Competitive Landscape And Company Profiles
24.1 Short Profiles
24.2 Eurofins Scientific SE
24.2.1 Company Overview
24.2.2 Products And Services
24.3 Charles River Laboratories Company
24.3.1 Company Overview
24.3.2 Products And Services
24.4 Labcorp Holding Inc.
24.4.1 Company Overview
24.4.2 Products And Services
24.5 Thermo Fisher Scientific Inc.
24.5.1 Company Overview
24.5.2 Products And Services
24.6 BGI Genomics Co. Ltd.
24.6.1 Company Overview
24.6.2 Products And Services
24.7 Novogene Co. Ltd.
24.7.1 Company Overview
24.7.2 Products And Services
24.8 GENEWIZ from Azenta
24.8.1 Company Overview
24.8.2 Products And Services
24.9 Frontage Laboratories
24.9.1 Company Overview
24.9.2 Products And Services
24.10 Metabolon Inc.
24.10.1 Company Overview
24.10.2 Products And Services
24.11 Somalogic Inc.
24.11.1 Company Overview
24.11.2 Products And Services
25 Germany Competitive Landscape And Company Profiles
25.1 Short Profiles
25.2 Labcorp Holding Inc. (including Covance)
25.2.1 Company Overview
25.2.2 Products And Services
25.3 Thermo Fisher Scientific Inc. (PPD)
25.3.1 Company Overview
25.3.2 Products And Services
25.4 Eurofins Scientific SE
25.4.1 Company Overview
25.4.2 Products And Services
25.5 Charles River Laboratories
25.5.1 Company Overview
25.5.2 Products And Services
25.6 BGI Genomics Co. Ltd.
25.6.1 Company Overview
25.6.2 Products And Services
25.7 Novogene Co. Ltd.
25.7.1 Company Overview
25.7.2 Products And Services
25.8 GENEWIZ from Azenta
25.8.1 Company Overview
25.8.2 Products And Services
25.9 Somalogic Inc. (SomaScan®)
25.9.1 Company Overview
25.9.2 Products And Services
25.10 Centogene GmbH
25.10.1 Company Overview
25.10.2 Products And Services
25.11 Frontage Laboratories
25.11.1 Company Overview
25.11.2 Products And Services
26 USA Competitive Landscape And Company Profiles
26.1 Short Profiles
26.2 Labcorp Holding Inc. (including Covance)
26.2.1 Company Overview
26.2.2 Products And Services
26.3 Thermo Fisher Scientific Inc. (PPD)
26.3.1 Company Overview
26.3.2 Products And Services
26.4 Charles River Laboratories
26.4.1 Company Overview
26.4.2 Products And Services
26.5 Eurofins Scientific SE
26.5.1 Company Overview
26.5.2 Products And Services
26.6 BGI Genomics Co. Ltd.
26.6.1 Company Overview
26.6.2 Products And Services
26.7 Novogene Co. Ltd.
26.7.1 Company Overview
26.7.2 Products And Services
26.8 GENEWIZ from Azenta
26.8.1 Company Overview
26.8.2 Products And Services
26.9 Frontage Laboratories
26.9.1 Company Overview
26.9.2 Products And Services
26.10 Somalogic Inc. (SomaScan®)
26.10.1 Company Overview
26.10.2 Products And Services
26.11 Metabolon Inc.
26.11.1 Company Overview
26.11.2 Products And Services
27 Japan Competitive Landscape And Company Profiles
27.1 Short Profiles
27.2 Eurofins Scientific SE
27.2.1 Company Overview
27.2.2 Products And Services
27.3 Charles River Laboratories
27.3.1 Company Overview
27.3.2 Products And Services
27.4 Thermo Fisher Scientific Inc. (PPD)
27.4.1 Company Overview
27.4.2 Products And Services
27.5 BGI Genomics Co. Ltd.
27.5.1 Company Overview
27.5.2 Products And Services
27.6 Labcorp Holding Inc. (including Covance)
27.6.1 Company Overview
27.6.2 Products And Services
27.7 Novogene Co. Ltd.
27.7.1 Company Overview
27.7.2 Products And Services
27.8 GENEWIZ from Azenta
27.8.1 Company Overview
27.8.2 Products And Services
27.9 Frontage Laboratories
27.9.1 Company Overview
27.9.2 Products And Services
27.10 Somalogic Inc. (SomaScan®)
27.10.1 Company Overview
27.10.2 Products And Services
27.11 Centogene GmbH
27.11.1 Company Overview
27.11.2 Products And Services
28 List Of Key Omics CRO Services Companies For The Countries
28.1.1 France
28.1.2 Italy
28.1.3 Spain
28.1.4 Rest Of Europe
28.1.5 Canada
28.1.6 China
28.1.7 India
29 Current Uses Of AI/ML In Technology Platforms In Omics CRO Services Market
29.1 Next-Generation Sequencing (NGS)
29.2 Microarray Technology
29.3 Mass Spectrometry
29.4 Chromatography
29.5 Bioinformatics Tools
29.6 Other Technology Platforms
30 List Of Largest Customer Companies Of Omics CRO Services
31 Relative Demand/Size Of Services In The Omics CRO Services Market.
31.1 Target Validation
31.2 De-Risking Projects
31.3 Hit-To-Lead
31.4 Biomarker Identification
31.5 Manufacturing Process Improvements
31.6 Drug Substance Analysis
31.7 Toxicology Evaluations
31.8 Visualization Of Data
31.9 AI/ML Interpretations
32 Usage Frequency Of AI/ML In Decision Making Across Omics CRO Projects
32.1 Genomics: Analyze Sequencing Data, And Identify Gene Patterns
32.2 Transcriptomics: Interpret RNA Data, And Quantify Expression
32.3 Proteomics: Classify Proteins, And Detect Modifications
32.4 Metabolomics: Analyze Metabolite Profiles, And Identify Patterns
32.5 Multi-Omics Integration: Integrate Datasets, And Avoid Outcome Incidents
32.6 Epigenomics: AI/ML in Chromatin & DNA Modification Analysis
32.7 Microbiomics: AI/ML in Microbiome Composition and Function
32.8 Pharmacogenomics & Toxicogenomics: AI/ML in Drug Response Prediction
32.9 Single-Cell Omics: AI/ML in Cell-Type Specific Analysis
32.10 Immunomics: AI/ML in Immune Repertoire and Immune Response Profiling
33 Unmet Needs Of The Omics CRO Services Market
33.1 Complexity and High Standards
33.2 Customized, Client-Centric Solutions
33.3 Efficient Data Management and Security
33.4 Faster, Cost-Effective Turnaround
33.5 Comprehensive Coverage Across Drug Development Phases
33.6 Patient Stratification and Recruitment
34 Opportunities And Threats To The Omics CRO Services Market
34.1 Opportunities
34.1.1 Expansion of Precision and Personalized Medicine
34.1.2 Rising Adoption of AI and Data Analytics
34.1.3 Increasing Outsourcing by Biotech and Pharma Firms
34.1.4 Growing Global Demand for Multi-omics Clinical Trials
34.1.5 Investment and Partnerships Across Emerging Markets
34.2 Threats
34.2.1 High Cost and Complexity of Omics Technologies
34.2.2 Data Integration Challenges
34.2.3 Talent scarcity
34.2.4 Ethical And Privacy Concerns
34.2.5 Rising competition
35 Technologies Change In The Omics CRO Services Market
35.1 Mass Spectrometry (MS) Platforms
35.2 Chromatography Systems
35.3 Bioinformatics and Data Analysis Pipelines
35.4 Sample Preparation and Handling Technologies
35.5 Proteomics Quantitation Methods
35.6 Metabolomics and Lipidomics Platforms
35.7 Multi-Omics Integration Tools
35.8 Data Storage and Sharing Technologies
36 Expertise Necessary To Compete In The Omics CRO Services Market
36.1 Core Technical Expertise
36.2 Multi-Omics Data Integration
36.3 End-to-End Service Delivery
36.4 Regulatory and Domain Knowledge
36.5 Emerging Trends and Strategic Positioning
37 Small Players In The Omics CRO Services Market (Except Genomics) In North America And Europe
37.1 North America
37.1.1 Dalton Bioanalytics
37.1.2 Sapient Bioanalytics
37.1.3 MS Bioworks Company
37.1.4 Panome Bio
37.1.5 Allumiqs
37.2 Europe
37.2.1 OmicScouts GmbH
37.2.2 Sciomics GmbH
37.2.3 PreOmics GmbH
37.2.4 Biognosys AG
37.2.5 GenomeScan
38 Competitive Benchmarking
39 Competitive Dashboard
40 Key Mergers And Acquisitions
40.1 Mapmygenome Acquired Microbiome Insights
40.2 Momentum Biotechnologies Acquired OmicScouts GmbH
40.3 Crown Bioscience Acquired Indivumed GmbH
41 Recent Development In Omics CRO Services Market
41.1 Cutting-Edge Facility Supports End-to-End Multi-Omics Research and Product InnovationI
42 Opportunities And Strategies
42.1 Global Omics CRO Services Market In 2029 – Countries Offering Most New Opportunities
42.2 Global Omics CRO Services Market In 2029 – Segments Offering Most New Opportunities
42.3 Global Omics CRO Services Market In 2029 – Growth Strategies
42.3.1 Market Trend Based Strategies
42.3.2 Competitor Strategies
43 Omics CRO Services Market, Conclusions And Recommendations
43.1 Conclusions
43.2 Recommendations
43.2.1 Product
43.2.2 Place
43.2.3 Price
43.2.4 Promotion
43.2.5 People
44 Appendix
44.1 Geographies Covered
44.2 Market Data Sources
44.3 Research Methodology
44.4 Currencies
44.5 The Business Research Company
44.6 Copyright and Disclaimer
